Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 6NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 30Prostatic Neoplasms 22Neoplasm Metastasis 20Breast Neoplasms 17Lung Neoplasms 16Colorectal Neoplasms 15Pancreatic Neoplasms 14Leukemia, Myeloid, Acute 14Ovarian Neoplasms 12Lymphoma 12Urinary Bladder Neoplasms 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Stomach Neoplasms 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 9Burkitt Lymphoma 9Sarcoma, Kaposi 8Pheochromocytoma 8Multiple Myeloma 8Melanoma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Endometrial Neoplasms 8Carcinoma, Renal Cell 8Squamous Cell Carcinoma of Head and Neck 7Neuroendocrine Tumors 7Lymphoma, Large B-Cell, Diffuse 7Kidney Neoplasms 7Glioma 7Thyroid Neoplasms 6

Interventions

2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NIH × Localized Prostate Cancer × Clear all
NCT05155046 2026-04-15

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
130 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡